Evidence map›Paper›PMID 27856430›Full record

ArticleAmerican journal of physiology. Cell physiology2017

Glycolysis and oxidative phosphorylation are essential for purinergic receptor-mediated angiogenic responses in vasa vasorum endothelial cells.

Martin Lapel, Philip Weston, Derek Strassheim, Vijaya Karoor, Nana Burns, Taras Lyubchenko, Petr Paucek, Kurt R Stenmark, Evgenia V Gerasimovskaya

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. CoClBiomedicines · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Martin LapelDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Philip WestonDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Derek StrassheimDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Vijaya KaroorDepartment of Medicine, University of Colorado Denver, Aurora, Colorado; and.
Nana BurnsDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Taras LyubchenkoDepartment of Medicine, University of Colorado Denver, Aurora, Colorado; and.
Petr PaucekDepartment of Pharmacology, University of Colorado Denver, Aurora, Colorado.
Kurt R StenmarkDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Evgenia V GerasimovskayaDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado; evgenia.gerasimovskaya@ucdenver.edu.
University of Colorado Denver · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Extracellular ATP: potential regulator of hypoxia-induced vasa vasorum neovasculaR01HL086783 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GERASIMOVSKAYA, EVGENIA V · 2008 to 2017
$4.2M
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary ArR01HL114887 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BULL, TODD M, BUTTRICK, PETER N. · 2012 to 2016
$3.4M
NHLBI NIH HHS P01 HL014985NHLBI NIH HHS R01 HL086783NHLBI NIH HHS R01 HL114887
6 · The paper itself

Abstract

Angiogenesis is an energy-demanding process; however, the role of cellular energy pathways and their regulation by extracellular stimuli, especially extracellular nucleotides, remain largely unexplored. Using metabolic inhibitors of glycolysis (2-deoxyglucose) and oxidative phosphorylation (OXPHOS) (oligomycin, rotenone, and FCCP), we demonstrate that glycolysis and OXPHOS are both essential for angiogenic responses of vasa vasorum endothelial cell (VVEC). Treatment with P2R agonists, ATP, and 2-methylthioadenosine diphosphate trisodium salt (MeSADP), but not P1 receptor agonist, adenosine, increased glycolytic activity in VVEC (measured by extracellular acidification rate and lactate production). Stimulation of glycolysis was accompanied by increased levels of phospho-phosphofructokinase B3, hexokinase (HK), and GLUT-1, but not lactate dehydrogenase. Moreover, extracellular ATP and MeSADP, and to a lesser extent adenosine, increased basal and maximal oxygen consumption rates in VVEC. These effects were potentiated when the cells were cultured in 20 mM galactose and 5 mM glucose compared with 25 mM glucose. Treatment with P2R agonists decreased phosphorylation of pyruvate dehydrogenase (PDH)-E1α and increased succinate dehydrogenase (SDH), cytochrome oxidase IV, and β-subunit of F

Indexed as

Oxidative PhosphorylationAnimalsCattleCells, CulturedEndothelial CellsGlycolysisMaleNeovascularization, PhysiologicReceptors, PurinergicVasa VasorumReceptors, Purinergicangiogenesiscellular metabolismendothelial cellsglycolysisOXPHOSpurinergic receptorsvasa vasorum

Identifiers

PMID27856430
PMCPMC5283894
OpenAlexW2551118580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.